Search Results1-16 of  16

  • 丸山 大 ID: 9000010396442

    Articles in CiNii:4

    • Equation of cancer treatment and management in Japan (2007)
    • Training of cancer experts (2008)
    • Standard therapies of hematological malignancies (2010)
  • 丸山 大 ID: 9000010572412

    Articles in CiNii:1

    • 座談会 悪性リンパ腫診療の向上のために--質の高い診断と治療を目指して (特集 悪性リンパ腫診療update in 2008--最新のエビデンスに基づく診断と治療) (2008)
  • 丸山 大 ID: 9000018395640

    Articles in CiNii:1

    • 血液がん患者を診る (特集 がん診療の考え方・進め方--患者と向き合うための基礎知識) -- (各がん種への対応を学ぶ) (2010)
  • 丸山 大 ID: 9000018840092

    Articles in CiNii:3

    • CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma : a randomised controlled trial (2007)
    • Primary bone lymphoma (2010)
    • 完全ヒト抗CD20抗体ofatumumabの慢性リンパ性白血病とB細胞リンパ腫に対する臨床試験 (特集 リツキシマブ導入後のB細胞腫瘍治療) (2010)
  • 丸山 大 ID: 9000018914038

    Articles in CiNii:1

    • VMP versus VTP in elderly patients with untreated multiple myeloma : a randomised trial (2012)
  • 丸山 大 ID: 9000397961366

    Articles in CiNii:1

    • Up-dated recommendation for the optimal use of bendamustine in Japan (2018)
  • 丸山 大 ID: 9000399559681

    Articles in CiNii:1

    • Novel agents for T-cell lymphoma (2018)
  • 丸山 大 ID: 9000405118555

    Articles in CiNii:1

    • Long-term follow-up data and transformation risk of follicular lymphoma in the rituximab era (2019)
  • MARUYAMA Dai ID: 9000001214293

    Articles in CiNii:33

    • Acquired hemophilia A successfully treated with immunosuppressive therapy and plasma exchange (2003)
    • Primary ocular adnexal MALT lymphoma (2008)
    • Novel monoclonal antibodies for the treatment of malignant lymphomas (2011)
  • MARUYAMA Dai ID: 9000258044892

    国立がん研究センター中央病院 血液腫瘍科 (2011 from CiNii)

    Articles in CiNii:1

    • Treatment of Burkitt lymphoma and Burkitt-like lymphoma (2011)
  • MARUYAMA Dai ID: 9000265255144

    国立がん研究センター中央病院 血液腫瘍科 (2014 from CiNii)

    Articles in CiNii:1

    • Treatment strategy of gray zone lymphomas (2014)
  • MARUYAMA Dai ID: 9000283114245

    国立がん研究センター中央病院 血液腫瘍科 (2014 from CiNii)

    Articles in CiNii:1

    • Recommendation for the optimal use of bendamustine in Japan (2014)
  • MARUYAMA Dai ID: 9000345434418

    Department of Hematology, National Cancer Center Hospital (2016 from CiNii)

    Articles in CiNii:1

    • Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102) (2016)
  • MARUYAMA Dai ID: 9000345434658

    Department of Hematology, National Cancer Center Hospital (2016 from CiNii)

    Articles in CiNii:1

    • Immune-checkpoint inhibitors in hematologic malignancies (2016)
  • MARUYAMA Dai ID: 9000365620770

    Hematology Division, National Cancer Center Hospital (2017 from CiNii)

    Articles in CiNii:1

    • Malignant lymphoma in adolescents and young adults: from the viewpoint of physicians (2017)
  • MARUYAMA Dai ID: 9000398393948

    Department of Hematology, National Cancer Center Hospital (2018 from CiNii)

    Articles in CiNii:1

    • Treatment strategy for high-grade B-cell lymphoma (2018)
Page Top